Sky Century Investment (SKYI) Profit After Tax (QoQ) (2012 - 2026)
Sky Century Investment (SKYI) Profit After Tax (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -173.52% |
| Feb 28, 2026 | 120.96% |
| Nov 30, 2025 | 21.20% |
| Aug 31, 2025 | -174.43% |
| May 31, 2025 | 51.22% |
| Feb 28, 2025 | 35.75% |
| Nov 30, 2024 | -184.93% |
| Aug 31, 2024 | -3.26% |
| May 31, 2024 | 60.59% |
| Aug 31, 2014 | -51.08% |
| May 31, 2014 | -17.47% |
| Feb 28, 2014 | 6.20% |
| Nov 30, 2013 | 35.70% |
| Aug 31, 2013 | -171.55% |
| May 31, 2013 | 30.95% |
| Feb 28, 2013 | -100.00% |
| Nov 30, 2012 | 73.08% |